◀ Back to NPY6R

NPY6R — SMAD1

Text-mined interactions from Literome

Mima et al., Lab Invest 2006 (Diabetes Mellitus, Experimental...) : PP2 , a Src tyrosine kinase inhibitor, and overexpression of dominant negative Src also reduced the phosphorylation of Smad1
Ungefroren et al., Curr Cancer Drug Targets 2011 : Likewise, PP2 and PP1 but not SU6656 effectively blocked TGF-ß1 induced activation of Smad2 and p38 MAPK and partially suppressed Smad activation and transcriptional activity on TGF-ß/Smad-responsive reporters of a kinase-active TßRI mutant ectopically expressed in Panc1 cells